首页> 外国专利> HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID, REDUCES FECAL CALPROTECTIN LEVELS AND PREVENTS CLINICAL RELAPSE IN ULCERATIVE COLITIS PATIENTS

HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID, REDUCES FECAL CALPROTECTIN LEVELS AND PREVENTS CLINICAL RELAPSE IN ULCERATIVE COLITIS PATIENTS

机译：高度纯化的二氧化萘烯酸，作为游离脂肪酸，减少粪便钙保护菌素水平并防止溃疡性结肠炎患者的临床复发

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a method of administering an effective dose of highly purified eicosapentaenoic acid as free-fatty acid (EPA-FFA) to reduce fecal calprotectin levels and reduce the risk of clinical relapse in UC patients. The eicosapentaenoic acid, in the free fatty acid (EPA-FFA) form, has a purity of at least 95%, and more preferably at least 99%.

机译：本发明涉及向施用有效剂量的高度纯化的己烯酮作为游离脂肪酸（EPA-FFA）的方法，以减少粪便酸蛋白水平，降低UC患者的临床复发风险。在游离脂肪酸（EPA-FFA）形式中，己酰亚苯乙烯酸的纯度至少为 95℃，更优选至少 99 / b>％。

著录项

公开/公告号US2021251935A1

专利类型
公开/公告日2021-08-19

原文格式PDF
申请/专利权人 S.L.A. PHARMA AG;
展开▼

申请/专利号US202117236383
发明设计人 JUSTIN SLAGEL;
展开▼

申请日2021-04-21
分类号A61K31/202;A61K45/06;A61P1;A61P1/04;
国家 US
入库时间 2022-08-24 20:42:08

相似文献

专利
外文文献
中文文献